| United States | Generally regulated as a dietary supplement when marketed for ingestion as a supplement. It is not approved by the FDA for safety or effectiveness before sale. | No general FDA premarket approval for dietary supplements. The responsible person must submit a New Dietary Ingredient notification when applicable and when the ingredient does not meet the applicable history-of-use requirements. | Avoid disease-treatment or disease-prevention claims. Structure/function claims require substantiation and generally require FDA notification within 30 days after first marketing. Required disclaimer applies when qualifying structure/function claims are used: “This statement has not been evaluated by the Food and Drug Administration...” | Use a compliant Supplement Facts panel, ingredient list, net quantity, name and place of business, domestic adverse-event contact information, allergen declaration where applicable, lot or batch identification, and an expiration or shelf-life statement supported by data. | Verify compliance with 21 CFR Part 111 current Good Manufacturing Practice requirements. Obtain specifications, identity and potency testing, contaminant testing, finished-product certificates of analysis, stability data, allergen controls, change-control procedures, recall procedures, and evidence that label claims are substantiated. | Medium |
| European Union | Classification varies by Member State. Melatonin gummies may be treated as food supplements, medicinal products, or another regulated category depending on dose, presentation, and claims. | Food supplements generally do not have one EU-wide premarket approval route, but national notification may be required. If classified as a medicinal product, marketing authorization is required before sale. | The authorized EU health-claim framework permits a sleep-onset claim only when the food provides 1 mg of melatonin per quantified portion, and a jet-lag claim only when the food provides 0.5 mg per quantified portion and the required conditions of use are met. Member-State enforcement and classification must be checked before sourcing. | Provide the food name, ingredient list, allergens, quantity of certain ingredients, net quantity, durability date, storage conditions, responsible food business operator, nutrition information where required, and the recommended daily portion. Include the required warning not to exceed the recommended daily dose and the statement that food supplements should not be used as a substitute for a varied diet and healthy lifestyle. | Confirm the target Member State's classification and notification process. Obtain EU food safety documentation, contaminant and microbiological specifications, stability data, traceability records, HACCP-based controls, packaging compliance evidence, and documentation supporting every health claim and dosage statement. | High |
| United Kingdom | Melatonin is generally treated as a medicinal substance in Great Britain. A product containing melatonin normally requires authorization as a medicine rather than being marketed as an ordinary food supplement. | A valid marketing authorization, traditional herbal registration where legally applicable, or another recognized medicine authorization route is required before medicinal marketing. Advertising and supply must follow the applicable medicines rules. | Do not source or market melatonin gummies as ordinary UK food supplements without a formal classification review. Medicinal indications, dosage, advertising, and presentation must match the authorized product information. | Medicinal packaging normally requires the authorized product name, active substance and strength, pharmaceutical form, route, dosage instructions, warnings, contraindications, storage conditions, batch number, expiry date, marketing authorization information, and required patient information. | Require evidence of the relevant UK authorization, a qualified-person and pharmacovigilance framework where applicable, compliant manufacturing, batch release, stability data, artwork approval, and import or wholesale authorization documentation. | High |
| Canada | Melatonin products are generally regulated as natural health products. A gummy format does not remove the product from the natural health product framework. | A product licence and Natural Product Number (NPN) are generally required before sale. The manufacturer, packager, labeller, or importer may also require a site licence. | Use only the approved medicinal or health claims, ingredients, dosage form, route, and directions authorized for the product. Claims must not exceed the scope of the product licence. | Use the approved product facts and labeling elements, including the product name, dosage form, medicinal and non-medicinal ingredients, recommended use, dose, duration of use, warnings, contraindications, source or importer information, lot number, expiry date, storage conditions, and the NPN. | Request a copy of the NPN and verify that it matches the exact formula, dosage form, strength, claims, manufacturer, and label. Obtain evidence of site-licence coverage, good manufacturing practices, raw-material identity, potency, contaminant testing, stability, traceability, and complaint-handling procedures. | High |
| Australia | Classification depends on the ingredient, dose, presentation, and claims. Melatonin products are generally subject to therapeutic-goods controls rather than being treated as unrestricted foods or ordinary supplements. | The product may require inclusion in the Australian Register of Therapeutic Goods and an appropriate listing or registration pathway before supply. The correct pathway must be confirmed with the Therapeutic Goods Administration for the intended formulation and claims. | Product claims must remain within the approved indication and permitted advertising framework. Do not assume that a product legally sold in another country can be imported or advertised in Australia without a separate classification and compliance review. | Therapeutic-goods labeling generally requires the approved product name, active ingredient and quantity, directions for use, warnings and precautions, storage conditions, batch number, expiry date, sponsor details, and the applicable Australian registration or listing identifier. | Verify the Australian regulatory status, sponsor or sponsor-authorized importer, manufacturing compliance, batch-release controls, stability evidence, analytical specifications, label approval, advertising compliance, and import documentation before placing a purchase order. | High |
| Cross-Market Sourcing Controls | A single global formula and label should not be assumed to be compliant in every market. Classification can change because of dosage, claims, warnings, packaging, or route of administration. | Complete a country-by-country regulatory assessment before signing a supply agreement. Confirm whether the importer, distributor, or local responsible party must hold a licence, registration, notification, or authorization. | Build the formula and claims around the strictest intended market. Avoid “cures insomnia,” “treats anxiety,” “prevents disease,” or similar disease claims unless the product is authorized as a medicine for that indication. | Reconcile the actual formula with the label declaration, serving size, melatonin amount, sweeteners, colors, allergens, warnings, age restrictions, storage conditions, lot coding, expiry dating, and local language requirements. | Before approval, obtain a signed specification, full bill of materials, raw-material CoAs, identity and potency methods, heavy-metal and microbiological results, pesticide or solvent testing where relevant, stability protocol, packaging compatibility data, allergen statement, audit rights, change-notification terms, recall process, and product-liability coverage. | Market-Specific |
